nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—MTOR—epithelium—membranous glomerulonephritis	0.133	0.215	CbGeAlD
Everolimus—FKBP1A—epithelium—membranous glomerulonephritis	0.119	0.193	CbGeAlD
Everolimus—MTOR—kidney—membranous glomerulonephritis	0.119	0.193	CbGeAlD
Everolimus—FKBP1A—kidney—membranous glomerulonephritis	0.107	0.173	CbGeAlD
Everolimus—FKBP1A—cortex of kidney—membranous glomerulonephritis	0.104	0.169	CbGeAlD
Everolimus—Tacrolimus—ALB—membranous glomerulonephritis	0.0428	1	CrCbGaD
Everolimus—CYP3A4—kidney—membranous glomerulonephritis	0.035	0.0567	CbGeAlD
Everolimus—MTOR—SREBF and miR33 in cholesterol and lipid homeostasis—ABCA1—membranous glomerulonephritis	0.0325	0.0957	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—RHOA—membranous glomerulonephritis	0.0288	0.0847	CbGpPWpGaD
Everolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—membranous glomerulonephritis	0.0287	0.0845	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—PTPRU—membranous glomerulonephritis	0.0249	0.0734	CbGpPWpGaD
Everolimus—MTOR—Costimulation by the CD28 family—HLA-DQA1—membranous glomerulonephritis	0.00925	0.0272	CbGpPWpGaD
Everolimus—MTOR—Alpha 6 Beta 4 signaling pathway—RHOA—membranous glomerulonephritis	0.00908	0.0267	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—SPARC—membranous glomerulonephritis	0.00886	0.026	CbGpPWpGaD
Everolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—RHOA—membranous glomerulonephritis	0.00884	0.026	CbGpPWpGaD
Everolimus—MTOR—IL4-mediated signaling events—CD40LG—membranous glomerulonephritis	0.0088	0.0259	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—HLA-DRB1—membranous glomerulonephritis	0.00727	0.0214	CbGpPWpGaD
Everolimus—MTOR—Costimulation by the CD28 family—HLA-DRB1—membranous glomerulonephritis	0.00658	0.0193	CbGpPWpGaD
Everolimus—MTOR—Wnt Signaling Pathway Netpath—RHOA—membranous glomerulonephritis	0.00631	0.0185	CbGpPWpGaD
Everolimus—MTOR—IFN-gamma pathway—IL1B—membranous glomerulonephritis	0.00618	0.0182	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—RHOA—membranous glomerulonephritis	0.00582	0.0171	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—HLA-DRB1—membranous glomerulonephritis	0.00556	0.0163	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00541	0.0159	CbGpPWpGaD
Everolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00522	0.0153	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—IL1B—membranous glomerulonephritis	0.0049	0.0144	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—IL1B—membranous glomerulonephritis	0.00474	0.0139	CbGpPWpGaD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.00472	0.0139	CbGpPWpGaD
Everolimus—MTOR—Leptin signaling pathway—RHOA—membranous glomerulonephritis	0.00471	0.0138	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—MMP9—membranous glomerulonephritis	0.00462	0.0136	CbGpPWpGaD
Everolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RHOA—membranous glomerulonephritis	0.00447	0.0131	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—C7—membranous glomerulonephritis	0.00436	0.0128	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—PLG—membranous glomerulonephritis	0.00432	0.0127	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—CD79A—membranous glomerulonephritis	0.00432	0.0127	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—RHOA—membranous glomerulonephritis	0.0043	0.0126	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—RHOA—membranous glomerulonephritis	0.0043	0.0126	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00423	0.0124	CbGpPWpGaD
Everolimus—MTOR—Leptin signaling pathway—IL1B—membranous glomerulonephritis	0.00396	0.0117	CbGpPWpGaD
Everolimus—MTOR—PI3K/AKT activation—RHOA—membranous glomerulonephritis	0.00371	0.0109	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—RHOA—membranous glomerulonephritis	0.00354	0.0104	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CFH—membranous glomerulonephritis	0.00346	0.0102	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—MMP9—membranous glomerulonephritis	0.00341	0.01	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—RHOA—membranous glomerulonephritis	0.00334	0.00983	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00304	0.00895	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—membranous glomerulonephritis	0.00303	0.0089	CbGpPWpGaD
Everolimus—FKBP1A—Disease—LRP2—membranous glomerulonephritis	0.00274	0.00806	CbGpPWpGaD
Everolimus—MTOR—Immune System—C7—membranous glomerulonephritis	0.00254	0.00747	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—MMP9—membranous glomerulonephritis	0.00225	0.00663	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00225	0.00661	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—RHOA—membranous glomerulonephritis	0.0021	0.00617	CbGpPWpGaD
Everolimus—MTOR—Immune System—CFH—membranous glomerulonephritis	0.00202	0.00593	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LRP2—membranous glomerulonephritis	0.00192	0.00565	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD40—membranous glomerulonephritis	0.00185	0.00544	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD79A—membranous glomerulonephritis	0.00174	0.00512	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—RHOA—membranous glomerulonephritis	0.00161	0.00474	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DQA1—membranous glomerulonephritis	0.00161	0.00472	CbGpPWpGaD
Everolimus—MTOR—Disease—LRP2—membranous glomerulonephritis	0.00154	0.00453	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD40LG—membranous glomerulonephritis	0.00142	0.00417	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—C3—membranous glomerulonephritis	0.00131	0.00384	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—C3—membranous glomerulonephritis	0.00125	0.00369	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APOE—membranous glomerulonephritis	0.00116	0.00342	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PLG—membranous glomerulonephritis	0.00115	0.00338	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APOA1—membranous glomerulonephritis	0.00115	0.00338	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	0.00114	0.00336	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD40—membranous glomerulonephritis	0.00112	0.0033	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LRP2—membranous glomerulonephritis	0.00108	0.00317	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD79A—membranous glomerulonephritis	0.00106	0.0031	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000974	0.00286	CbGpPWpGaD
Everolimus—FKBP1A—Disease—RHOA—membranous glomerulonephritis	0.00088	0.00259	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—C3—membranous glomerulonephritis	0.000874	0.00257	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD40LG—membranous glomerulonephritis	0.00086	0.00253	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APOE—membranous glomerulonephritis	0.000814	0.00239	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000804	0.00237	CbGpPWpGaD
Everolimus—MTOR—Immune System—C3—membranous glomerulonephritis	0.00076	0.00224	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000693	0.00204	CbGpPWpGaD
Everolimus—MTOR—Disease—APOE—membranous glomerulonephritis	0.000653	0.00192	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PLG—membranous glomerulonephritis	0.000647	0.0019	CbGpPWpGaD
Everolimus—MTOR—Disease—APOA1—membranous glomerulonephritis	0.000646	0.0019	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000616	0.00181	CbGpPWpGaD
Everolimus—MTOR—Disease—RHOA—membranous glomerulonephritis	0.000495	0.00145	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—C3—membranous glomerulonephritis	0.000492	0.00145	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000489	0.00144	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOE—membranous glomerulonephritis	0.000458	0.00135	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000452	0.00133	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1B—membranous glomerulonephritis	0.000451	0.00133	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	0.000384	0.00113	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000346	0.00102	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	0.000342	0.00101	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00033	0.000969	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000275	0.000809	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	0.000221	0.000649	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	0.000145	0.000427	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	0.000143	0.000422	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	0.000114	0.000334	CbGpPWpGaD
